China Health Group Inc.
China Health Group Inc. (8225.HK) Stock Competitors & Peer Comparison
See (8225.HK) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Diagnostics & Research Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| 8225.HK | HK$0.15 | +0.00% | 145.3M | 7.30 | HK$0.02 | N/A |
| 2359.HK | HK$124.90 | +0.81% | 357B | 16.65 | HK$7.50 | +1.46% |
| 2268.HK | HK$61.15 | -0.89% | 76.9B | 45.30 | HK$1.35 | N/A |
| 3347.HK | HK$42.70 | -2.91% | 51.8B | 36.19 | HK$1.18 | +0.76% |
| 6127.HK | HK$21.22 | +1.43% | 29.1B | 47.16 | HK$0.45 | +0.15% |
| 9860.HK | HK$4.20 | +0.00% | 3B | 140.00 | HK$0.03 | N/A |
| 6667.HK | HK$7.38 | -0.14% | 1.7B | 46.13 | HK$0.16 | N/A |
| 8037.HK | HK$0.69 | -8.00% | 673.3M | -9.86 | -HK$0.07 | N/A |
| 2325.HK | HK$0.83 | +3.75% | 485.8M | 83.00 | HK$0.01 | N/A |
| 0928.HK | HK$0.07 | +1.37% | 136.9M | -3.70 | -HK$0.02 | N/A |
Stock Comparison
8225.HK vs 2359.HK Comparison April 2026
8225.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 8225.HK stands at 145.3M. In comparison, 2359.HK has a market cap of 357B. Regarding current trading prices, 8225.HK is priced at HK$0.15, while 2359.HK trades at HK$124.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
8225.HK currently has a P/E ratio of 7.30, whereas 2359.HK's P/E ratio is 16.65. In terms of profitability, 8225.HK's ROE is -0.03%, compared to 2359.HK's ROE of +0.28%. Regarding short-term risk, 8225.HK is less volatile compared to 2359.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 8225.HK.Check 2359.HK's competition here